secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001213900-24-106238
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma extends equity line with White Lion to Dec 2025, adds rapid share purchase mechanism
--------------------------------------------------------------------------------

- Amendment extends existing up-to-$50M stock purchase agreement from Dec 30, 2024 to Dec 30, 2025.
- New 'Rapid Purchase' mechanism allows expedited share sales at lowest traded price on notice date.
- Rapid purchase limit is the lesser of 20% of average daily trading volume or investment limit divided by highest close over five days.
- Standard purchase discount remains 97% (up to $25M) then 98%; rapid purchases use lowest traded price (0% discount).
- Company delivers Rapid Purchase Notice by 11:00 a.m. NY time with concurrent DWAC transfer; payment due next business day by 5 p.m.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/0001213900-24-106238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/ea0223902-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-106238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer